Pharmacogenomic prediction of immune-related adverse events from immune checkpoint inhibitors among Asian patients
40
Saved in:
Main Authors: | Huang, Yiqing, Aminkeng, Folefac, Wong, Alvin SC, Tay, Sen Hee, Zhao, Joseph J, Ang, Yvonne, Soo, Ross A, Goh, Boon Cher |
---|---|
Other Authors: | MEDICINE |
Format: | Conference or Workshop Item |
Published: |
LIPPINCOTT WILLIAMS & WILKINS
2022
|
Subjects: | |
Online Access: | https://scholarbank.nus.edu.sg/handle/10635/235036 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Similar Items
-
Factors Predictive of Primary Resistance to Immune Checkpoint Inhibitors in Patients with Advanced Non-Small Cell Lung Cancer
by: Huang, Yiqing, et al.
Published: (2023) -
Neutrophil-to-Lymphocyte Ratio Predicts Development of Immune-Related Adverse Events and Outcomes from Immune Checkpoint Blockade: A Case-Control Study
by: Lee, Pei Yi, et al.
Published: (2021) -
Risk factors for immune-related adverse events from anti-PD-1 or anti-PD-L1 treatment in an Asian cohort of nonsmall cell lung cancer patients
by: Huang, Yiqing, et al.
Published: (2022) -
Factors Predictive of Primary Resistance to Immune Checkpoint Inhibitors in Asian Patients with Advanced NSCLC
by: Huang, Y, et al.
Published: (2023) -
Immune-related adverse events from immune checkpoint inhibitors: Review of risk factors in clinical practice
by: Jennis Meanwatthana
Published: (2020)